profit from every $100 of sales.
$0$100
Keen Vision Acquisition Corporation Ordinary Shares
We have no price for Keen Vision Acquisition Corporation Ordinary Shares since 11 August 2026. It may have been taken over, merged or renamed, so the figures below are from then.
$12.01-0.66% today
+3.5% since Oct 10, 25
1-year low $11.301-year high $13.38
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average.
0%20% a year
You pay $33.18 for every $1 of profit it makes in a year.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Keen Vision Acquisition Corporation Ordinary Shares sold, what it kept, and what it did with the cash.
Sales went from $0 in 2022 to $0 in 2025, with $1.91 million of profit last year.
SalesProfit
Keen Vision Acquisition Corporation Ordinary Shares vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Keen Vision Acquisition Corporation Ordinary Shares | 33.2× · No profit yet | ||
 Churchill Capital Corp X | No profit yet | ||
 Drugs Made In America Acquisition II | 155.8× · No profit yet | ||
 Bain Capital GSS Investment Cor | No profit yet | ||
 Cantor Equity Partners IV | 96.3× · No profit yet |
AI analysis
An AI analyst reads Keen Vision Acquisition Corporation Ordinary Shares's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 0 | 0 | 0 | 0 | |
| – | – | – | – | |
| -0 | -0 | -1 | -1 | |
| -0 | -0 | -1 | -1 | |
| -0 | 1 | 7 | 2 | |
| -0.00 | -0.05 | 0.41 | 0.19 | |
| – | – | – | – | |
| – | – | – | – | |
| – | – | – | – |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 0 | 156 | 70 | 57 |
| Cash | 0 | 1 | 0 | 0 |
| Total debt | 0 | – | 1 | 3 |
| Total liabilities | 0 | 3 | 4 | 7 |
| 0 | 153 | 66 | 50 | |
| 17 | 4 | 18 | 10 | |
| -0.3% | -0.2% | -1.7% | -1.1% | |
| -3.3% | 1.0% | 11.2% | 3.8% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -0 | -1 | -1 | -1 | |
| – | – | – | – | |
| -0 | -1 | -1 | -1 | |
| Dividends paid | – | – | – | – |
| – | 0 | 92 | 18 | |
| – | – | – | – |
Valuation
- 33.2×
- –
- –
- -5.2×
- –
- –
- –
- -1.2%
- 3.0%
- 0.0%
Profitability
- 0.0%
- 0.0%
- 0.0%
- 0.0%
- -6.5%
- 2.6%
- 3.6%
- 10.8%
- -6.5%
- –
Growth
- –
- –
- +31.4%
- –
- −26.3%
Financial health
- -0.0×
- 0.00
- 0.0%
- –
- 0.02
- 0.02
- 0.00
How it ranks in Financial Services
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 3%of 758
Bottom 7%of 605
Bottom 16%of 883
Bottom 20%of 927
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 8, 2026 | 0.01 | – | – |
| Mar 5, 2026 | 0.04 | – | – |
| Nov 3, 2025 | 0.07 | – | – |
| Jul 23, 2025 | 0.05 | – | – |
| May 13, 2025 | 0.05 | – | – |
| Mar 7, 2025 | 0.06 | – | – |
| Nov 4, 2024 | 0.08 | – | – |
| Jul 25, 2024 | 0.09 | – | – |
News
Trump says he is not keen on a deal with Iran as U.S. reportedly prepares for 'massive bombing'CNBC · Oct 8, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
22No pass
Benjamin Graham
29No pass
Philip Fisher
36No pass
Peter Lynch
60Pass
Joel Greenblatt
7No pass
Charlie Munger
26No pass
Terry Smith
21No pass
Questions about Keen Vision Acquisition Corporation Ordinary Shares
Is Keen Vision Acquisition Corporation Ordinary Shares a good stock to buy?
A business with weak numbers that is not profitable yet. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Keen Vision Acquisition Corporation Ordinary Shares AI analysis
What does Keen Vision Acquisition Corporation Ordinary Shares do?
Keen Vision Acquisition Corporation intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, and related business combination with one or more businesses or entities. It is in Shell Companies.
Does Keen Vision Acquisition Corporation Ordinary Shares pay a dividend?
No. Keen Vision Acquisition Corporation Ordinary Shares does not pay a dividend at the moment; in 2025 it returned $18.1 million to shareholders by buying back its own shares.
Is Keen Vision Acquisition Corporation Ordinary Shares stock halal?
Questionable. Keen Vision Acquisition Corporation Ordinary Shares sits in a grey zone: scholars disagree about its industry. How we check
Who are Keen Vision Acquisition Corporation Ordinary Shares's competitors?
The largest listed companies in the same industry are Churchill Capital Corp X, Drugs Made In America Acquisition II, Bain Capital GSS Investment Cor and Cantor Equity Partners IV. The peers table on this page compares their profit, growth and price with Keen Vision Acquisition Corporation Ordinary Shares's.
Prices: daily closes to Aug 11, 2026. Fundamentals: company reports via invest-like data.